Your browser doesn't support javascript.
loading
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial.
Poh, Xuan Ying; Tan, Chee Wah; Lee, I Russel; Chavatte, Jean-Marc; Fong, Siew-Wai; Prince, Tessa; Hartley, Catherine; Yeoh, Aileen Y Y; Rao, Suma; Chia, Po Ying; Ong, Sean W X; Lee, Tau Hong; Sadarangani, Sapna P; Lin, Ray J H; Lim, Clarissa; Teo, Jefanie; Lim, Daniel R X; Chia, Wanni; Hiscox, Julian A; Ng, Lisa F P; Ren, Ee Chee; Lin, Raymond T P; Renia, Laurent; Lye, David Chien; Wang, Lin-Fa; Young, Barnaby E.
  • Poh XY; National Centre for Infectious Diseases, Singapore, Singapore.
  • Tan CW; Emerging Infectious Diseases Programme, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Lee IR; National Centre for Infectious Diseases, Singapore, Singapore.
  • Chavatte JM; National Centre for Infectious Diseases, Singapore, Singapore.
  • Fong SW; National Public Health Laboratory, Singapore, Singapore.
  • Prince T; A*STAR Infectious Diseases Lab, Agency for Science Technology and Research, Singapore, Singapore.
  • Hartley C; Department of Infection Biology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Yeoh AYY; Department of Infection Biology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Rao S; Emerging Infectious Diseases Programme, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Chia PY; National Centre for Infectious Diseases, Singapore, Singapore.
  • Ong SWX; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Lee TH; National Centre for Infectious Diseases, Singapore, Singapore.
  • Sadarangani SP; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Lin RJH; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Lim C; National Centre for Infectious Diseases, Singapore, Singapore.
  • Teo J; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Lim DRX; National Centre for Infectious Diseases, Singapore, Singapore.
  • Chia W; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Hiscox JA; National Centre for Infectious Diseases, Singapore, Singapore.
  • Ng LFP; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Ren EC; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Lin RTP; National Centre for Infectious Diseases, Singapore, Singapore.
  • Renia L; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Lye DC; National Centre for Infectious Diseases, Singapore, Singapore.
  • Wang LF; National Centre for Infectious Diseases, Singapore, Singapore.
  • Young BE; National Centre for Infectious Diseases, Singapore, Singapore.
Clin Infect Dis ; 75(12): 2088-2096, 2022 12 19.
Article en En | MEDLINE | ID: mdl-35543372
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Año: 2022 Tipo del documento: Article